Featuring perspectives from Dr Harold J
Burstein, Dr Javier Cortés, Prof Rebecca A Dent, Dr Kevin Kalinsky,
Dr Hope S Rugo and Dr Joyce O’Shaughnessy, moderated by Dr Rugo,
including the following topics:
Introduction (0:00)
Optimizing the Management of HER2-Positive Metastatic Breast
Cancer (mBC) — Dr Cortés (3:52)
Individualized Selection of Up-Front Therapy for Patients with
HR-Positive, HER2-Negative mBC — Dr Kalinsky (23:10)
Available Therapies for Patients with HR-Positive,
HER2-Negative Disease Progressing on CDK4/6 Inhibition — Dr
Burstein (48:09)
Current and Potential Future Role of HER2-Targeted Therapy for
HER2-Low and HER2-Ultralow Disease — Dr O’Shaughnessy
(1:04:00)
Current and Future Strategies for Patients with
Endocrine-Refractory HR-Positive mBC — Dr Rugo (1:22:28)
Selection and Sequencing of Therapy for Patients with
Metastatic Triple-Negative Breast Cancer — Prof Dent (1:42:51)
Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.